The alpha-lipoic acid derivative DHLHZn: a new therapeutic agent for acute lung injury in vivo.
Shoji Y, Takeuchi H, Fukuda K, Fukunaga K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Miyasho T, Hiratsuka T, Inomata M, Betsuyaku T, Kitagawa Y.
Shoji Y, et al. Among authors: hiratsuka t.
Inflamm Res. 2017 Sep;66(9):803-811. doi: 10.1007/s00011-017-1059-x. Epub 2017 Jun 1.
Inflamm Res. 2017.
PMID: 28573312